Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Portfolio Pulse from Avi Kapoor
Several major stocks, including Intuit, Workday, and others, are experiencing declines in Friday's pre-market trading. Intuit's shares fell despite better-than-expected Q3 earnings due to weak guidance for the current quarter. Workday also saw a significant drop after lowering its forward guidance despite strong Q1 earnings.
May 24, 2024 | 9:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cognyte Software shares declined 6.9% to $6.94 in pre-market trading.
Cognyte Software saw a 6.9% decline in pre-market trading, reflecting a negative sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Genmab shares fell 4.5% to $28.01 in pre-market trading.
Genmab experienced a 4.5% decline in pre-market trading, indicating a negative market reaction.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Intuit's shares fell 6.3% in pre-market trading despite better-than-expected Q3 earnings and a boosted full-year outlook, due to weak guidance for the current quarter.
Intuit's strong Q3 earnings and improved full-year outlook were overshadowed by weak guidance for the current quarter, leading to a 6.3% drop in pre-market trading.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Lithium Americas shares fell 2.4% to $4.58 in pre-market trading.
Lithium Americas saw a 2.4% decline in pre-market trading, indicating a slight negative sentiment.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 50
NEGATIVE IMPACT
NetEase shares declined 3.7% to $91.15 in pre-market trading after reporting worse-than-expected Q1 revenue.
NetEase's worse-than-expected Q1 revenue led to a 3.7% decline in pre-market trading.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Ryanair shares slipped 2.3% to $124.72 in pre-market trading.
Ryanair experienced a 2.3% decline in pre-market trading, indicating a slight negative sentiment.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 50
NEGATIVE IMPACT
Summit Therapeutics shares dipped 21.2% to $3.40 in pre-market trading.
Summit Therapeutics experienced a significant 21.2% drop in pre-market trading, indicating a negative market reaction.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Workday shares fell 12.4% in pre-market trading after the company posted strong Q1 earnings but lowered its forward guidance.
Despite strong Q1 earnings, Workday's lowered forward guidance led to a significant 12.4% drop in pre-market trading.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100